Sri Lanka, Dec. 24 -- Amid renewed concerns over the country's lack of a WHO-accredited laboratory, Sri Lanka has begun upgrading its drug testing facilities to meet World Health Organization (WHO) accreditation standards.

This follows the probe into the withdrawn batches of the Ondansetron and request of the relevant Indian company to send samples for global testing.

Speaking to the Daily Mirror, National Medicines Regulatory Authority (NMRA) Chairman Dr. Ananda Wijewickrama said the issue has come into sharp focus during the ongoing probe into withdrawn batches of the drug Ondansetron and a request by the relevant Indian manufacturer to send samples for international testing.

He said Sri Lanka's continued dependence on external labor...